Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours ...

People with shorter telomeres, the protective caps at the end of chromosomes, inside their white blood cells may be more ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

Regular flossing (at least once a week) may reduce the risk of stroke linked to blood clots from the heart and conditions ...

Mild electrical brain stimulation did not further improve motor recovery in stroke survivors, according to late-breaking science presented at the American Stroke Association's International Stroke ...

The widely used FAST acronym remains the best tool for helping bystanders recognize stroke symptoms, despite efforts to expand it to BE-FAST.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Neither a placebo procedure nor two different doses of transcranial brain stimulation, which send electrical signals through the skull, improved mobility recovery in stroke survivors receiving ...

Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics.

Stroke survivors were more likely to have little or no disability after 90 days if a clot was removed from a large brain artery followed by the injection of the clot-dissolving medication tenecteplase ...